Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential effects. Initial findings suggest that this higher dosage may enhance the drug's ability to control blood levels, potentially offering more significant outcomes for individuals with insulin resistance. Further investigation is underway to fully evalua